- Amikacin sulfate
-
- $48.00 / 100mg
-
2026-03-05
- CAS:149022-22-0
- Min. Order:
- Purity: 99.86%
- Supply Ability: 10g
- Amikacin sulfate salt
-
- $1.00 / 1g
-
2026-02-02
- CAS:149022-22-0
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 50tons
|
| | Amikacin sulfate salt Basic information |
| Product Name: | Amikacin sulfate salt | | Synonyms: | AMIKACIN SULFATE 1:1.8;Amikacin sulfate salt;(2S)-4-AMino-N-{(1R,2S,3S,4R,5S)-5-aMino-2-[(3-aMino-3-deoxy-a-D-glucopyranosyl)oxy]-4-[(6-aMino-6-deoxy-a-D-glucopyranosyl)oxy]-3-hydroxycyclohexyl}-2-hydroxybutanaMide sulfate (1:2);AMIKASIN SULFATE;AMIKACIN SULFATE SALT, AMINOGLYCOSID;Amikacin sulfate(5:9);mikacin disulfate salt;liusuanamukaxonm | | CAS: | 149022-22-0 | | MF: | C22H45N5O17S | | MW: | 683.68 | | EINECS: | 254-648-6 | | Product Categories: | APIs | | Mol File: | 149022-22-0.mol |  |
| | Amikacin sulfate salt Chemical Properties |
| storage temp. | Inert atmosphere,2-8°C | | solubility | H2O: soluble50mg/mL | | form | solid | | color | white to off-white | | biological source | synthetic | | InChIKey | HIBICIOPDUTNRR-BOEHXBESSA-N | | SMILES | OS(O)(=O)=O.NCC[C@@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O |
| WGK Germany | 2 | | RTECS | WK1961200 | | Storage Class | 11 - Combustible Solids | | Hazard Classifications | Skin Sens. 1 |
| | Amikacin sulfate salt Usage And Synthesis |
| Uses | Amikacin is an aminoglycoside antibiotic commonly used in the treatment of drug-resistant mycobacteria . It is used to study organism-directed delivery of antibiotics as well as drug resistance . | | General Description | Chemical structure: aminoglycoside | | Biochem/physiol Actions | Amikacin prevents bacterial protein synthesis by binding to the 30S ribosome subunit and inducing mRNA misreading. | | in vivo | Amikacin (320 mg/kg; subcutaneous injection; daily; for 10 days; male Fischer rats) treatment increases the chance of serious hearing loss in rats in vivo[3]. | Animal Model: | Male Fischer 344 rats (40-50-day-old)[3] | | Dosage: | 320mg/kg | | Administration: | Subcutaneous injection; daily; for 10 days | | Result: | Induced hearing loss in rats.
|
| | IC 50 | Aminoglycoside |
| | Amikacin sulfate salt Preparation Products And Raw materials |
|